Application | Comment | Organism |
---|---|---|
drug development | the enzyme is a possible antifungal drug target | Cryptococcus neoformans var. grubii serotype A |
Cloned (Comment) | Organism |
---|---|
recombinant expression of GFP-tagged enzyme targeted to mitochondria | Cryptococcus neoformans var. grubii serotype A |
Protein Variants | Comment | Organism |
---|---|---|
additional information | generation of a CNAG_02565 deletion mutant, the deletion impairs mitochondrial functions, phenotype, overview | Cryptococcus neoformans var. grubii serotype A |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
mitochondrion | - |
Cryptococcus neoformans var. grubii serotype A | 5739 | - |
Metals/Ions | Comment | Organism | Structure |
---|---|---|---|
Fe2+ | required, in a Fe-S cluster | Cryptococcus neoformans var. grubii serotype A |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
(R)-2-hydroxybutane-1,2,4-tricarboxylate | Cryptococcus neoformans var. grubii serotype A | - |
(Z)-but-1-ene-1,2,4-tricarboxylate + H2O | - |
? | |
(R)-2-hydroxybutane-1,2,4-tricarboxylate | Cryptococcus neoformans var. grubii serotype A H99 / ATCC 208821 / CBS 10515 / FGSC 9487 | - |
(Z)-but-1-ene-1,2,4-tricarboxylate + H2O | - |
? | |
(R)-2-hydroxybutane-1,2,4-tricarboxylate + H2O | Cryptococcus neoformans var. grubii serotype A | - |
(1R,2S)-1-hydroxybutane-1,2,4-tricarboxylate | - |
? | |
(R)-2-hydroxybutane-1,2,4-tricarboxylate + H2O | Cryptococcus neoformans var. grubii serotype A H99 / ATCC 208821 / CBS 10515 / FGSC 9487 | - |
(1R,2S)-1-hydroxybutane-1,2,4-tricarboxylate | - |
? | |
(Z)-but-1-ene-1,2,4-tricarboxylate + H2O | Cryptococcus neoformans var. grubii serotype A | - |
(1R,2S)-1-hydroxybutane-1,2,4-tricarboxylate | - |
? | |
(Z)-but-1-ene-1,2,4-tricarboxylate + H2O | Cryptococcus neoformans var. grubii serotype A H99 / ATCC 208821 / CBS 10515 / FGSC 9487 | - |
(1R,2S)-1-hydroxybutane-1,2,4-tricarboxylate | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Cryptococcus neoformans var. grubii serotype A | J9VIU5 | - |
- |
Cryptococcus neoformans var. grubii serotype A H99 / ATCC 208821 / CBS 10515 / FGSC 9487 | J9VIU5 | - |
- |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
(R)-2-hydroxybutane-1,2,4-tricarboxylate | - |
Cryptococcus neoformans var. grubii serotype A | (Z)-but-1-ene-1,2,4-tricarboxylate + H2O | - |
? | |
(R)-2-hydroxybutane-1,2,4-tricarboxylate | - |
Cryptococcus neoformans var. grubii serotype A H99 / ATCC 208821 / CBS 10515 / FGSC 9487 | (Z)-but-1-ene-1,2,4-tricarboxylate + H2O | - |
? | |
(R)-2-hydroxybutane-1,2,4-tricarboxylate + H2O | - |
Cryptococcus neoformans var. grubii serotype A | (1R,2S)-1-hydroxybutane-1,2,4-tricarboxylate | - |
? | |
(R)-2-hydroxybutane-1,2,4-tricarboxylate + H2O | - |
Cryptococcus neoformans var. grubii serotype A H99 / ATCC 208821 / CBS 10515 / FGSC 9487 | (1R,2S)-1-hydroxybutane-1,2,4-tricarboxylate | - |
? | |
(Z)-but-1-ene-1,2,4-tricarboxylate + H2O | - |
Cryptococcus neoformans var. grubii serotype A | (1R,2S)-1-hydroxybutane-1,2,4-tricarboxylate | - |
? | |
(Z)-but-1-ene-1,2,4-tricarboxylate + H2O | - |
Cryptococcus neoformans var. grubii serotype A H99 / ATCC 208821 / CBS 10515 / FGSC 9487 | (1R,2S)-1-hydroxybutane-1,2,4-tricarboxylate | - |
? |
Synonyms | Comment | Organism |
---|---|---|
CNAG_02565 | - |
Cryptococcus neoformans var. grubii serotype A |
Homoaconitase | - |
Cryptococcus neoformans var. grubii serotype A |
LYS4 | - |
Cryptococcus neoformans var. grubii serotype A |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
Fe-S cluster | - |
Cryptococcus neoformans var. grubii serotype A |
Organism | Comment | Expression |
---|---|---|
Cryptococcus neoformans var. grubii serotype A | the gene CNAG_02565 is significantly downregulated in the cfo1 mutant | down |
General Information | Comment | Organism |
---|---|---|
malfunction | deletion of the CNAG_02565 gene results in lysine auxotrophy. The lys4 mutant shows increased sensitivity to oxidative stress, agents that challenge cell wall/membrane integrity, and azole antifungal drugs. The phenotype is due in part to impaired mitochondrial function as a result of LYS4 deletion, which disrupts iron homeostasis in the organelle. The lys4 mutant is attenuated virulence in a mouse inhalation model of cryptococcosis. Loss of the enzyme results in organelle dysfunction due to a potential impact on Fe-S levels | Cryptococcus neoformans var. grubii serotype A |
physiological function | the enzyme expression is regulated by iron levels and by the iron-related transcription factors Hap3 and HapX. The enzyme is essential for lysine biosynthesis and is required for full virulence. The iron metabolism and homeostasis have a large influence on the virulence of Cryptococcus neoformans | Cryptococcus neoformans var. grubii serotype A |